U.S. Sen. Tammy Baldwin
Press Release

U.S. Senator Tammy Baldwin Demands Answers About Outrageous Price Hike For Lifesaving Anti-Overdose Drug

"...this startling price hike is very concerning."

By - Feb 8th, 2017 11:35 am

WASHINGTON, D.C. – U.S. Senator Tammy Baldwin joined a group of thirty-one Senators, led by Senator Patrick Leahy (D-VT), in demanding answers from a leading pharmaceutical company about the dramatic price hike for a life-saving medication used to respond to opioid overdoses.

Recent reports unveiled that drug maker Kaléo Pharmaceuticals, which manufactures an easy-to-use injector device containing the overdose-reversing drug naloxone, raised its price from $690 in 2014, to $4,500 currently. While the Evzio device has the potential to help thousands of individuals survive drug overdoses, the Senators wrote that the inexplicable price hike “threatens to price-out families and communities that depend on naloxone to save lives.”

“At a time when Congress has worked to expand access to naloxone products and to assist state and local communities to equip first responders with this life-saving drug, this startling price hike is very concerning,” the Senators wrote Wednesday to Kaléo Pharmaceuticals CEO Spencer Williamson.

The bipartisan Comprehensive Addiction and Recovery Act (CARA), which was signed into law last year, includes a Leahy-authored provision to help rural communities obtain the overdose-reversing drug naloxone.  Rural locations have the highest death rates in the country from opioid poisoning, and Naloxone has the potential to save more lives in these areas.

In addition to Baldwin and Leahy, the letter was signed by Senators Al Franken (D-MN), Christopher Murphy (D-CT), Jack Reed (D-RI), Dick Durbin (D-IL), Sheldon Whitehouse (D-RI), Maria Cantwell (D-WA), Dianne Feinstein (D-CA), Claire McCaskill (D-MO), Jeanne Shaheen (D-NH), Angus King (I-ME), Richard Blumenthal (D-CT), Edward J. Markey (D-MA), Maggie Hassan (D-NH), Amy Klobuchar (D-MN), Heidi Heitkamp (D-ND), Elizabeth Warren (D-MA), Tammy Duckworth (D-IL), Kirsten Gillibrand (D-NY), Joe Donnelly (D-IN), Jon Tester (D-Mont.), Bernie Sanders (I-Vt.), Sherrod Brown (D-Ohio), Debbie Stabenow (D-MI), Tom Udall (D-NM), Tim Kaine (D-VA), Mark Warner, (D-VA), Gary Peters (D-MI), Jeff Merkley (D-OR) and Cory Booker (D-NJ).

A copy of the letter to Kaléo Pharmaceuticals is available here.

Mentioned in This Press Release

Recent Press Releases by U.S. Sen. Tammy Baldwin

Bipartisan VA Accountability Reform One Step Closer to Senate Passage

Committee on Veterans’ Affairs approves bipartisan legislation, now heads to full Senate for vote

Senators Baldwin, Markey, Menendez, Shaheen Call for Increased Federal Funding to Combat Opioid Epidemic

"We request that the FY2018 appropriations bill reflect the magnitude of this public health crisis by increasing federal investment in addressing opioid and all substance use disorders across HHS agencies."

Senator Baldwin Supports Legislation that Takes Action on Student Debt Crisis

Student loan debt has swelled to $1.4 trillion, surpassing total amount of credit card debt

Leave a Reply

Your email address will not be published. Required fields are marked *